Trial reportThe British journal of psychiatry : the journal of mental science2017
Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial.
Erratum issuedOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph
Trial report in The British journal of psychiatry : the journal of mental science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers, 5 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 5 pooled it
5.0field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 5 syntheses or guidelines pooled it, 62 citations in OpenAlex.
- Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: a systematic review and network meta-analysis.Molecular psychiatry · 2024Pooled it
- Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis.Expert opinion on drug safety · 2022Pooled it
- The effect of ketamine on cognition, anxiety, and social functioning in adults with psychiatric disorders: A systematic review and meta-analysis.Frontiers in neuroscience · 2022Pooled it
- Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.The Cochrane database of systematic reviews · 2021Pooled it
- Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review.The Psychiatric quarterly · 2020Pooled it
- Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy: a randomized controlled trial.Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)Trial
- Effect of ECT-anesthetics on reorientation time.European archives of psychiatry and clinical neuroscience · 2026Article
- Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy.Wiener klinische Wochenschrift · 2025Review
- Prediction of individual treatment allocation between electroconvulsive therapy or ketamine using the Personalized Advantage Index.NPJ digital medicine · 2025Article
- Ketamine and Esketamine in Clinical Trials: FDA-Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations.Clinical pharmacology and therapeutics · 2025Review
- Article
- Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review.BJPsych open · 2021Review
- Use of Nitrous Oxide to Facilitate Induction for Electroconvulsive Therapy: A Case Report.The American journal of case reports · 2020Article
- The Combination of Propofol and Ketamine Does Not Enhance Clinical Responses to Electroconvulsive Therapy in Major Depression-The Results From the KEOpS Study.Frontiers in pharmacology · 2020Article
- Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials.General psychiatry · 2020Article
- Ketamine and depression: a narrative review.Drug design, development and therapy · 2019Review
- Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial - CORRIGENDUM.The British journal of psychiatry : the journal of mental science · 2018Article
- A review of ketamine's role in ECT and non-ECT settings.Neuropsychiatric disease and treatment · 2018Review
- Frequency and Duration of Course of ECT Sessions: An Appraisal of Recent Evidence.Indian journal of psychological medicineReview
- Adjunct Ketamine in Electroconvulsive Therapy.Innovations in clinical neuroscienceArticle
Corrections and comments
- Erratum issued
Authors and funding
8 authors at 4 institutions in 1 country.
Gordon FernieGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK g.fernie@abdn.ac.uk.
James CurrieGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK.
Jennifer S PerrinGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK.
Caroline A StewartGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK.
Virginica AndersonGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK.
Daniel M BennettGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK.
Steven HayGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK.
Ian C ReidGordon Fernie, PhD, Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen. Aberdeen, UK; James Currie, MBChB, BSc, Jennifer S. Perrin, PhD, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Caroline A. Stewart, BSc, PhD, Division of Neuroscience, University of Dundee, Dundee, UK; Virginica Anderson, MD, FRCA, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Daniel M. Bennett, MBChB, MRCPsych, MD, MMED, Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Steven Hay, MBChB, MRCPsych, NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK; Ian C. Reid (deceased), PhD, MRCPsych, previously at Division of Applied Medicine (Psychiatry), University of Aberdeen, Aberdeen and NHS Grampian, Royal Cornhill Hospital, Aberdeen, UK.
NHS Grampian · GBRoyal Cornhill Hospital · GBUniversity of Aberdeen · GBUniversity of Dundee · GB
Funding
Chief Scientist Office
Abstract
PubMed holds no abstract for this paper.
Indexed as
Electroconvulsive TherapyAdolescentAdultAgedAnestheticsAntidepressive AgentsCombined Modality TherapyDouble-Blind MethodFemaleHumansKetamineMajor Depressive DisorderMaleMiddle AgedPropofolTreatment OutcomeAnestheticsAntidepressive AgentsKetaminePropofol
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.